Cargando…

Blood-Based Biomarkers in Hepatitis B Virus-Related Hepatocellular Carcinoma, Including the Viral Genome and Glycosylated Proteins

Hepatitis B virus (HBV) infection is a major risk factor for hepatocellular carcinoma (HCC) development and is a global public health issue. High performance biomarkers can aid the early detection of HCC development in HBV-infected individuals. In addition, advances in the understanding of the patho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hayashi, Sanae, Nagaoka, Katsuya, Tanaka, Yasuhito
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540379/ https://www.ncbi.nlm.nih.gov/pubmed/34681709 http://dx.doi.org/10.3390/ijms222011051

Ejemplares similares

Viral Biomarkers for Hepatitis B Virus-Related Hepatocellular Carcinoma Occurrence and Recurrence
por: Liu, Yuanyuan, et al.
Publicado: (2021)

Physician perspectives on the management of viral hepatitis and hepatocellular carcinoma in Myanmar
por: Kim, Yoona A., et al.
Publicado: (2017)

Novel Biomarkers of Hepatitis B and Hepatocellular Carcinoma: Clinical Significance of HBcrAg and M2BPGi
por: Baudi, Ian, et al.
Publicado: (2020)

Viral hepatitis and hepatocellular carcinoma
por: Michielsen, Peter P, et al.
Publicado: (2005)

Mac‐2 Binding Protein Glycosylation Isomer as a Hepatocellular Carcinoma Marker in Patients With Chronic Hepatitis B or C Infection
por: Jun, Tomi, et al.
Publicado: (2019)

Development of hepatocellular carcinoma from various phases of chronic hepatitis B virus infection
por: Suzuki, Takanori, et al.
Publicado: (2021)

The effect of chronic viral hepatitis on prognostic value of inflammatory biomarkers in hepatocellular carcinoma
por: Sellers, Cortlandt M., et al.
Publicado: (2021)

Viral Hepatitis and Hepatocellular Carcinoma: State of the Art
por: Datfar, Toofan, et al.
Publicado: (2021)

A novel anti-HBV agent, E-CFCP, restores Hepatitis B virus (HBV)-induced senescence-associated cellular marker perturbation in human hepatocytes
por: Takamatsu, Yuki, et al.
Publicado: (2023)

SOX4 as biomarker in hepatitis B virus-associated hepatocellular carcinoma
por: Huang, Jian-Lv, et al.
Publicado: (2021)

Clusterin and Related Scoring Index as Potential Early Predictors of Response to Sorafenib in Hepatocellular Carcinoma
por: Narahara, Satoshi, et al.
Publicado: (2021)

Hepatitis B core-related antigen: A novel and promising surrogate biomarker to guide anti-hepatitis B virus therapy
por: Inoue, Takako, et al.
Publicado: (2023)

Search in the Literature for Viral Hepatitis and Hepatocellular Carcinoma in Iran
por: Kabir, Ali
Publicado: (2013)

Viral Hepatitis and Hepatocellular Carcinoma Prevention Strategy in Japan
por: Oda, Toshitsugu
Publicado: (1999)

Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma
por: D'souza, Simmone, et al.
Publicado: (2020)

Curcumin and Photobiomodulation in Chronic Viral Hepatitis and Hepatocellular Carcinoma
por: Ailioaie, Laura Marinela, et al.
Publicado: (2020)

Treatment for Viral Hepatitis as Secondary Prevention for Hepatocellular Carcinoma
por: Alqahtani, Saleh A., et al.
Publicado: (2021)

Circulating predictive and diagnostic biomarkers for hepatitis B virus-associated hepatocellular carcinoma
por: Van Hees, Stijn, et al.
Publicado: (2016)

Alcohol and hepatitis virus-dysregulated lncRNAs as potential biomarkers for hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Novel biomarkers for the management of chronic hepatitis B
por: Inoue, Takako, et al.
Publicado: (2020)

Hepatitis B virus infection and hepatocellular carcinoma in sub-Saharan Africa: Implications for elimination of viral hepatitis by 2030?
por: Amponsah-Dacosta, Edina
Publicado: (2021)

Hepatitis B Virus Genome Asymmetry in Hepatocellular Carcinoma
por: Shokrgozar, Zahra, et al.
Publicado: (2012)

Drug Discovery Study Aimed at a Functional Cure for HBV
por: Watanabe, Takehisa, et al.
Publicado: (2022)

Transition of Antibody to Hepatitis C Virus from Chronic Hepatitis to Hepatocellular Carcinoma
por: Kiyosawa, Kendo, et al.
Publicado: (1990)

Hepatitis Viruses and Human Hepatocellular Carcinoma
por: Kew, Michael C.
Publicado: (1997)

Hepatitis C virus to hepatocellular carcinoma
por: Jahan, Shah, et al.
Publicado: (2012)

Hepatitis C Virus and Hepatocellular Carcinoma
por: Kanda, Tatsuo, et al.
Publicado: (2013)

Hepatitis D Virus and Hepatocellular Carcinoma
por: Farci, Patrizia, et al.
Publicado: (2021)

Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
por: Hiotis, Spiros P, et al.
Publicado: (2012)

Therapeutic Modifications without Discontinuation of Atezolizumab Plus Bevacizumab Therapy Are Associated with Favorable Overall Survival and Time to Progression in Patients with Unresectable Hepatocellular Carcinoma
por: Tokunaga, Takayuki, et al.
Publicado: (2023)

Blood Biomarkers Predict Survival Outcomes in Patients with Hepatitis B Virus-Induced Hepatocellular Carcinoma Treated with PD-1 Inhibitors
por: Huang, Rui, et al.
Publicado: (2022)

Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma
por: Teng, Chiao-Fang, et al.
Publicado: (2020)

Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma
por: Liao, Xiwen, et al.
Publicado: (2019)

Characterization of glycosylation regulator-mediated glycosylation modification patterns and tumor microenvironment infiltration in hepatocellular carcinoma
por: Zhao, Linlin, et al.
Publicado: (2022)

Prevalence of viral hepatitis markers in Korean patients with hepatocellular carcinoma.
por: Huh, K., et al.
Publicado: (1998)

mTOR in Viral Hepatitis and Hepatocellular Carcinoma: Function and Treatment
por: Wang, Zhuo, et al.
Publicado: (2014)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Risk Factors and Prevention of Viral Hepatitis-Related Hepatocellular Carcinoma
por: Zhang, Xinhe, et al.
Publicado: (2021)

Advanced Nanotheranostics of CRISPR/Cas for Viral Hepatitis and Hepatocellular Carcinoma
por: Kong, Huimin, et al.
Publicado: (2021)

Successful Treatment of Oral Lichen Planus with Direct-Acting Antiviral Agents after Liver Transplantation for Hepatitis C Virus-Associated Hepatocellular Carcinoma
por: Nagao, Yumiko, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9mu7cdt0kb9imqc219piii4m03